Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-05-28

Clinical Trial Update: UCLA-Amity Parolee Health Promotion Study [NA]

View source ↗

Summary

The UCLA-Amity Parolee Health Promotion Study (NCT01844414) has completed, focusing on hepatitis B, hepatitis C, HIV infection, and substance use disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, Los Angeles | Conditions: Hepatitis B, Hepatitis C | NA | Status: COMPLETED